To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ( ` LNG-IUS ' ) and usual medical treatment for women with menorrhagia in primary care ; and compare the cost-effectiveness findings using two alternative measures of quality of life .